Increasing the uptake in a general practice prostate cancer screening programme.
Neil LimayeDaniele ZorzatoAaruran NadarajasundaramSabrina B Y OngPublished in: BMJ open quality (2022)
Our project identified patients that may potentially have undiagnosed prostate pathology. However, a key factor for not reaching our goal was blood test refusal. This was further exacerbated by the COVID-19 pandemic, impacting the capacity to disseminate appropriate information to the local population on the importance of PSA screening.
Keyphrases
- prostate cancer
- general practice
- radical prostatectomy
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- primary care
- peritoneal dialysis
- prognostic factors
- quality improvement
- clinical trial
- study protocol
- patient reported outcomes
- social media
- health information
- patient reported
- benign prostatic hyperplasia